{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:46:24Z","timestamp":1784310384657,"version":"3.55.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Alterations in the peripheral (e.g., serum, plasma, platelet) concentrations of arginine and its related catabolic products (i.e., ornithine, citrulline) in the urea and nitric oxide cycles have been reported to be associated with major depressive disorder (MDD). The meta-analysis herein aimed to explore the association between the concentration of peripheral arginine, its catabolic products and MDD, as well as to discuss the possible role of arginine catabolism in the onset and progression of MDD. PubMed, EMBASE, PsycINFO and Web of Science were searched from inception to June 2020. The protocol for the meta-analysis herein has been registered at the Open Science Framework [<jats:ext-link>https:\/\/doi.org\/10.17605\/osf.io\/7fn59<\/jats:ext-link>]. In total, 745 (47.5%) subjects with MDD and 823 (52.5%) healthy controls (HCs) from 13 articles with 16 studies were included. Fifteen of the included studies assessed concentrations of peripheral arginine, eight assessed concentrations of ornithine, and six assessed concentrations of citrulline. Results indicated that: (1) the concentrations of arginine, ornithine, and citrulline were not significantly different between individuals with MDD and HCs when serum, plasma and platelet are analyzed together, (2) in the subgroups of serum samples, the concentrations of arginine were lower in individuals with MDD than HCs, and (3) concurrent administration of psychotropic medications may be a confounding variable affecting the concentrations of arginine, ornithine, and citrulline. Our findings herein do not support the hypothesis that arginine catabolism between individuals with MDD and HCs are significantly different. The medication status and sample types should be considered as a key future research avenue for assessing arginine catabolism in MDD.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.686973","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T06:18:59Z","timestamp":1637216339000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Mingyue","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna M. W.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990and#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e48002","DOI":"10.1371\/journal.pone.0048002","article-title":"Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention","volume":"7","author":"Olin","year":"2012","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: an inflammatory illness?","volume":"83","author":"Krishnadas","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1002090","DOI":"10.1371\/journal.pmed.1002090","article-title":"Genetic and environmental risk for chronic pain and the contribution of risk variants for major depressive disorder: a family-based mixed-model analysis","volume":"13","author":"McIntosh","year":"2016","journal-title":"PLoS Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/08039488.2016.1191535","article-title":"Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany","volume":"70","author":"Block","year":"2016","journal-title":"Nord J Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","article-title":"Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis","volume":"238","author":"Cao","year":"2018","journal-title":"J Affect Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.1801609115","article-title":"Acetyl-l-carnitine deficiency in patients with major depressive disorder","volume":"115","author":"Nasca","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0924-977X(95)00033-L","article-title":"Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression","volume":"5","author":"Altamura","year":"1995","journal-title":"Eur Neuropsychopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1046\/j.1471-4159.1995.65062652.x","article-title":"gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders","volume":"65","author":"Do","year":"1995","journal-title":"J Neurochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite profiling identifies pathways associated with metabolic risk in humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11306-011-0357-5","article-title":"Serum amino acid profiles and their alterations in colorectal cancer","volume":"8","author":"Leichtle","year":"2012","journal-title":"Metabolomics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.psychres.2012.05.027","article-title":"Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder","volume":"200","author":"Xu","year":"2012","journal-title":"Psychiatry Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pnpbp.2015.08.016","article-title":"The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder","volume":"65","author":"Maurya","year":"2016","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jad.2017.12.030","article-title":"Global arginine bioavailability ratio is decreased in patients with major depressive disorder","volume":"229","author":"Ali-Sisto","year":"2018","journal-title":"J Affect Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12035-018-1051-7","article-title":"Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder","volume":"56","author":"Maes","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3945\/ajcn.112.048025","article-title":"Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine-nitric oxide metabolic system in humans","volume":"97","author":"Mariotti","year":"2013","journal-title":"Am J Clin Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.fsi.2020.01.026","article-title":"Arginine, ornithine and citrulline supplementation in rainbow trout: Free amino acid dynamics and gene expression responses to bacterial infection","volume":"98","author":"Clark","year":"2020","journal-title":"Fish Shellfish Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0143397","DOI":"10.1371\/journal.pone.0143397","article-title":"Nitric oxide-related biological pathways in patients with major depression","volume":"10","author":"Baranyi","year":"2015","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21752-9","article-title":"Metabolic profile associated with distinct behavioral coping strategies of 129Sv and Bl6 mice in repeated motility test","volume":"8","author":"Narvik","year":"2018","journal-title":"Sci Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00726-010-0797-7","article-title":"A role for PPAR\u03b1 in the regulation of arginine metabolism and nitric oxide synthesis","volume":"41","author":"Guelzim","year":"2011","journal-title":"Amino Acids."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.csbj.2016.02.003","article-title":"Metabolomic profiling of post-mortem brain reveals changes in amino acid and glucose metabolism in mental illness compared with controls","volume":"14","author":"Zhang","year":"2016","journal-title":"Comput Struct Biotechnol J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000056256","article-title":"Association of serum nitric oxide levels with depressive symptoms: a study with end-stage renal failure patients","volume":"70","author":"Papageorgiou","year":"2001","journal-title":"Psychother Psychosom."},{"key":"B27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J Affect Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.pnpbp.2006.04.008","article-title":"Increased plasma nitric oxide level associated with suicide attempt in depressive patients","volume":"30","author":"Kim","year":"2006","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1099-1077(199607)11:4&lt;309::AID-HUP775&gt;3.0.CO;2-B","article-title":"Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness?","volume":"11","year":"2015","journal-title":"Human Psychopharmacol Clin Exper."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.eurpsy.2008.01.010","article-title":"S.08.04 The nitric oxide pathway in anxiety and stress-related disorders","volume":"23","author":"Wegener","year":"2007","journal-title":"Eur Neuropsychopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.pnpbp.2008.08.010","article-title":"Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test","volume":"32","author":"Jesse","year":"2008","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jad.2012.02.008","article-title":"Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients","volume":"140","author":"Pinto","year":"2012","journal-title":"J Affect Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease. Nature reviews","volume":"14","author":"Lundberg","year":"2015","journal-title":"Drug Disc."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-19624-9","volume-title":"Essentials of Biochemistry","author":"Fromm","year":"2012"},{"key":"B36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2015.10.015","article-title":"Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation","volume":"52","author":"Bersani","year":"2016","journal-title":"Brain Behav Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0278-5846(99)00100-1","article-title":"Increased serum arginase activity in depressed patients","volume":"24","author":"Elg\u00fcn","year":"2000","journal-title":"Progress Neuropsychopharmacol Biol Psychiatr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.arcmed.2012.07.006","article-title":"Plasma amino acid levels discriminate between control subjects and mildly depressed elderly women","volume":"43","author":"Mayoral-Mariles","year":"2012","journal-title":"Arch Med Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.neuroscience.2009.08.029","article-title":"Age-related changes in arginine and its metabolites in memory-associated brain structures","volume":"164","author":"Liu","year":"2009","journal-title":"Neuroscience."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1038\/tp.2016.145","article-title":"Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants","volume":"6","author":"Rotroff","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00213-018-4992-7","article-title":"Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects","volume":"235","author":"Moaddel","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"B42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroscience.2010.10.076","article-title":"L-Ornithine attenuates corticotropin-releasing factor-induced stress responses acting at GABA A receptors in neonatal chicks","volume":"172","author":"Kurata","year":"2010","journal-title":"Neuroscience."},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000096042","article-title":"Nitric oxide and neopterin in bipolar affective disorder","volume":"54","author":"Hoekstra","year":"2006","journal-title":"Neuropsychobiology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","year":"1998","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/nm.2544","article-title":"Requirement of argininosuccinate lyase for systemic nitric oxide production","volume":"17","author":"Erez","year":"2011","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0165-0327(03)00135-6","article-title":"Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression","volume":"80","author":"Selley","year":"2004","journal-title":"J Affect Disord."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e21068","DOI":"10.1097\/MD.0000000000021068","article-title":"Association between arginine catabolism and major depressive disorder: a protocol for the systematic review and meta-analysis of metabolic pathway","volume":"99","author":"Cao","year":"2020","journal-title":"Medicine."},{"key":"B49","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e13332","DOI":"10.1111\/eci.13332","article-title":"Association between diabetes mellitus and lung cancer: Meta-analysis","volume":"50","author":"Yi","year":"2020","journal-title":"Eur J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08039489850139067","article-title":"The biology of depression in Arab culture","volume":"52","author":"Abou-Saleh","year":"1998","journal-title":"Nord J Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1600-0447.1998.tb10004.x","article-title":"Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity","volume":"97","author":"Maes","year":"1998","journal-title":"Acta Psychiatr Scand."},{"key":"B54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000026491","article-title":"Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment","volume":"37","author":"Mauri","year":"1998","journal-title":"Neuropsychobiology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000054933","article-title":"Predictive value of amino acids in the treatment of major depression with fluvoxamine","volume":"44","author":"Mauri","year":"2001","journal-title":"Neuropsychobiology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/cns.12372","article-title":"Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors","volume":"21","author":"Woo","year":"2015","journal-title":"CNS Neurosci Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s00213-017-4712-8","article-title":"Decreased serum L-arginine and L-citrulline levels in major depression","volume":"234","author":"Hess","year":"2017","journal-title":"Psychopharmacology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpsychires.2017.09.014","article-title":"Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets","volume":"96","author":"Ogawa","year":"2018","journal-title":"J Psychiatr Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpsychires.2019.10.004","article-title":"Altered plasma levels of arginine metabolites in depression","volume":"120","author":"Ozden","year":"2020","journal-title":"J Psychiatr Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1172\/JCI13848","article-title":"An experiment of nature: genetic L-arginine deficiency and NO insufficiency","volume":"108","author":"Loscalzo","year":"2001","journal-title":"J. Clin Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"682134","DOI":"10.3389\/fmolb.2021.682134","article-title":"A comparison of serum and plasma blood collection tubes for the integration of epidemiological and metabolomics data","volume":"8","author":"Sotelo-Orozco","year":"2021","journal-title":"Front Mol Biosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","article-title":"Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor","volume":"568","author":"Dhir","year":"2007","journal-title":"Eur J Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/jn\/130.11.2626","article-title":"Arginine nutrition and cardiovascular function","volume":"130","author":"Wu","year":"2000","journal-title":"J Nutr."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.686973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T06:19:05Z","timestamp":1637216345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.686973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":64,"alternative-id":["10.3389\/fpsyt.2021.686973"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.686973","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"686973"}}